ClinicalTrials.gov record
Completed Phase 1 Interventional

PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

ClinicalTrials.gov ID: NCT05639751

Public ClinicalTrials.gov record NCT05639751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT3789 as Monotherapy and in Combination With Docetaxel in Participants With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Study identification

NCT ID
NCT05639751
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Prelude Therapeutics
Industry
Enrollment
135 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1, 2023
Primary completion
Sep 30, 2025
Completion
Sep 30, 2025
Last update posted
Oct 15, 2025

2023 – 2025

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
University of California, Davis Comprehensive Cancer Center Sacramento California 95817
UCLA Hematology/Oncology - Santa Monica Santa Monica California 90404
Smilow Cancer Hospital Phase 1 Unit New Haven Connecticut 06511
AdventHealth Medical Group Oncology Research at Celebration Celebration Florida 34747
Mayo Clinic, Jacksonville Jacksonville Florida 32224
Winship Cancer Institute Atlanta Georgia 30322
Northwestern Memorial Hospital Chicago Illinois 60611
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21287
Massachusetts General Hospital Boston Massachusetts 02114
Dana Farber Cancer Institute Boston Massachusetts 02215
Mayo Clinic, Rochester Rochester Minnesota 55905
Washington University School of Medicine - Siteman Cancer Center St Louis Missouri 63110
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York New York 10016
New York Presbyterian Hospital - Columbia University Medical Center New York New York 10032
Memorial Sloan Kettering Cancer Center New York New York 10065
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Cleveland Clinic Cleveland Ohio 44195
Providence Cancer Institute Franz Clinic Portland Oregon 97213
The University of Texas MD Anderson Cancer Center Houston Texas 77030
NEXT Virginia Fairfax Virginia 22031

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05639751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2025 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05639751 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →